Please login to the form below

Not currently logged in
Email:
Password:

Helsinn

This page shows the latest Helsinn news and features for those working in and with pharma, biotech and healthcare.

Fishawack acquires brand communications agency Healthcircle

Fishawack acquires brand communications agency Healthcircle

The group is a network of medical communications and marketing organisation companies and has a portfolio of pharma and healthcare clients including Roche, Swiss pharma group Helsinn and phytomedicines company Schwabe

Latest news

  • Danish biopharma company wins R&D award

    Since 1999, Zealand's scientists have built a pipeline that includes five compounds in clinical development, three of which have been out-licensed to pharmaceutical companies, sanofi-aventis, Wyeth and Helsinn

  • FDA approves PONV injection

    Developed by Eisai Corporation of North America, its US subsidiary MGI Pharma, and Helsinn Healthcare SA (based in Switzerland), Aloxi has been shown to reduce the severity of PONV. ... Riccardo Braglia, CEO of Helsinn Healthcare SA, said: ìThis is an

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    Late stage licences can also command relatively low upfront fees. For example, Helsinn has licensed pracinostat, which is phase III-ready, for $15m upfront plus $5m equity payment. ... 540. MEI Pharma (US). Helsinn (CH). Licence. Pracinostat, phase

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics